High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival
Katharine K Brieger,Minh Tung Phung,Bhramar Mukherjee,Kelly M Bakulski,Hoda Anton-Culver,Elisa V Bandera,David D L Bowtell,Daniel W Cramer,Anna DeFazio,Jennifer A Doherty,Sian Fereday,Renée Turzanski Fortner,Aleksandra Gentry-Maharaj,Ellen L Goode,Marc T Goodman,Holly R Harris,Keitaro Matsuo,Usha Menon,Francesmary Modugno,Kirsten B Moysich,Bo Qin,Susan J Ramus,Harvey A Risch,Mary Anne Rossing,Joellen M Schildkraut,Britton Trabert,Robert A Vierkant,Stacey J Winham,Nicolas Wentzensen,Anna H Wu,Argyrios Ziogas,Lilah Khoja,Kathleen R Cho,Karen McLean,Jean Richardson,Bronwyn Grout,Anne Chase,Cindy McKinnon Deurloo,Kunle Odunsi,Brad H Nelson,James D Brenton,Kathryn L Terry,Paul D P Pharoah,Andrew Berchuck,Gillian E Hanley,Penelope M Webb,Malcolm C Pike,Celeste Leigh Pearce,Ovarian Cancer Association Consortium
DOI: https://doi.org/10.1158/1055-9965.EPI-21-0977
Abstract:Background: There is suggestive evidence that inflammation is related to ovarian cancer survival. However, more research is needed to identify inflammation-related factors that are associated with ovarian cancer survival and to determine their combined effects. Methods: This analysis used pooled data on 8,147 women with invasive epithelial ovarian cancer from the Ovarian Cancer Association Consortium. The prediagnosis inflammation-related exposures of interest included alcohol use; aspirin use; other nonsteroidal anti-inflammatory drug use; body mass index; environmental tobacco smoke exposure; history of pelvic inflammatory disease, polycystic ovarian syndrome, and endometriosis; menopausal hormone therapy use; physical inactivity; smoking status; and talc use. Using Cox proportional hazards models, the relationship between each exposure and survival was assessed in 50% of the data. A weighted inflammation-related risk score (IRRS) was developed, and its association with survival was assessed using Cox proportional hazards models in the remaining 50% of the data. Results: There was a statistically significant trend of increasing risk of death per quartile of the IRRS [HR = 1.09; 95% confidence interval (CI), 1.03-1.14]. Women in the upper quartile of the IRRS had a 31% higher death rate compared with the lowest quartile (95% CI, 1.11-1.54). Conclusions: A higher prediagnosis IRRS was associated with an increased mortality risk after an ovarian cancer diagnosis. Further investigation is warranted to evaluate whether postdiagnosis exposures are also associated with survival. Impact: Given that pre- and postdiagnosis exposures are often correlated and many are modifiable, our study results can ultimately motivate the development of behavioral recommendations to enhance survival among patients with ovarian cancer.